Stock 9729 TOKAI CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials TOKAI Corp.

Equities

9729

JP3552250007

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-26 am EDT 		5-day change 1st Jan Change
2,100 JPY -0.10% Intraday chart for TOKAI Corp. +1.25% +0.48%
Apr. 22 Tokai Carbon Completes Payment of Over 30 Million Yen for Shares as Compensation MT
Apr. 19 Enechange's CEO Disposes Of 445,900 Shares MT

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 97,132 104,557 85,785 60,694 69,713 73,935 - -
Enterprise Value (EV) 1 70,308 75,325 53,666 27,258 35,015 73,935 73,935 73,935
P/E ratio 19.3 x 20 x 15.7 x 10.5 x 11.4 x 13.1 x 12.7 x 11.8 x
Yield 1.11% 1.02% 1.24% 2.44% 3.03% 2.67% 2.6% 2.79%
Capitalization / Revenue 0.83 x 0.87 x 0.73 x 0.49 x 0.54 x 0.54 x 0.51 x 0.49 x
EV / Revenue 0.83 x 0.87 x 0.73 x 0.49 x 0.54 x 0.54 x 0.51 x 0.49 x
EV / EBITDA 8.92 x 9.24 x 7.84 x 4.97 x 5.74 x 5.74 x 5.52 x 5.32 x
EV / FCF 17 x 22.6 x 14.8 x 17.9 x 29.6 x 108 x 16 x 13.7 x
FCF Yield 5.87% 4.43% 6.78% 5.59% 3.38% 0.93% 6.25% 7.29%
Price to Book 1.48 x 1.53 x 1.17 x 0.79 x 0.85 x 0.87 x 0.83 x 0.8 x
Nbr of stocks (in thousands) 36,001 35,600 35,581 35,206 35,227 35,207 - -
Reference price 2 2,698 2,937 2,411 1,724 1,979 2,100 2,100 2,100
Announcement Date 5/10/19 5/8/20 5/7/21 5/9/22 5/11/23 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 116,349 120,809 118,009 123,484 130,184 137,422 144,376 151,031
EBITDA 1 10,893 11,321 10,940 12,205 12,144 12,879 13,385 13,905
EBIT 1 7,311 7,908 7,294 8,252 7,855 7,850 8,260 8,905
Operating Margin 6.28% 6.55% 6.18% 6.68% 6.03% 5.71% 5.72% 5.9%
Earnings before Tax (EBT) 1 7,790 7,783 7,944 8,647 8,940 8,250 8,635 9,280
Net income 1 5,026 5,255 5,481 5,806 6,106 5,630 5,840 6,280
Net margin 4.32% 4.35% 4.64% 4.7% 4.69% 4.1% 4.04% 4.16%
EPS 2 139.6 146.6 154.0 164.4 173.4 159.9 165.9 178.4
Free Cash Flow 1 5,706 4,630 5,815 3,395 2,356 685 4,622 5,390
FCF margin 4.9% 3.83% 4.93% 2.75% 1.81% 0.5% 3.2% 3.57%
FCF Conversion (EBITDA) 52.38% 40.9% 53.15% 27.82% 19.4% 5.32% 34.53% 38.76%
FCF Conversion (Net income) 113.53% 88.11% 106.09% 58.47% 38.58% 12.17% 79.14% 85.83%
Dividend per Share 2 30.00 30.00 30.00 42.00 60.00 56.00 54.50 58.50
Announcement Date 5/10/19 5/8/20 5/7/21 5/9/22 5/11/23 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2020 S1 2021 S1 2021 S2 2022 Q2 2022 S1 2022 Q3 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2023 S2 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4
Net sales 1 60,686 57,449 60,560 30,575 60,269 31,832 63,215 31,547 32,544 64,091 33,355 32,738 66,093 33,491 34,374 67,865 35,553 34,005
EBITDA - - - - - - - - - - - - - - - - - -
EBIT 1 3,947 2,909 4,385 2,273 3,828 2,344 4,424 1,633 1,934 3,567 1,991 2,297 4,288 1,623 2,061 3,684 2,182 1,984
Operating Margin 6.5% 5.06% 7.24% 7.43% 6.35% 7.36% 7% 5.18% 5.94% 5.57% 5.97% 7.02% 6.49% 4.85% 6% 5.43% 6.14% 5.83%
Earnings before Tax (EBT) 1 4,031 3,242 4,702 2,508 4,169 2,469 4,478 1,723 - 4,695 2,007 2,238 4,245 1,730 - 3,829 2,254 2,166
Net income 1 2,685 2,192 3,289 1,685 2,799 1,645 3,007 1,189 - 3,130 1,270 1,706 2,976 1,238 - 2,626 1,501 1,501
Net margin 4.42% 3.82% 5.43% 5.51% 4.64% 5.17% 4.76% 3.77% - 4.88% 3.81% 5.21% 4.5% 3.7% - 3.87% 4.22% 4.41%
EPS 74.63 61.58 - - 79.03 46.71 - 33.79 - 88.91 36.04 - - 35.19 - 74.62 42.63 -
Dividend per Share 15.00 15.00 - - 19.00 - - - - 21.00 - - - - - 25.00 - -
Announcement Date 11/8/19 11/6/20 5/7/21 11/8/21 11/8/21 2/10/22 5/9/22 8/5/22 11/7/22 11/7/22 2/10/23 5/11/23 5/11/23 8/10/23 11/10/23 11/10/23 2/9/24 -
1JPY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position 26,824 29,232 32,119 33,436 34,698 - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 5,706 4,630 5,815 3,395 2,356 685 4,622 5,390
ROE (net income / shareholders' equity) 7.9% 7.8% 7.7% 7.7% 7.7% 6.8% 6.8% 6.8%
ROA (Net income/ Total Assets) 8.39% 8.49% 8.08% 8.53% 7.46% - - -
Assets 1 59,884 61,877 67,818 68,040 81,874 - - -
Book Value Per Share 2 1,824 1,920 2,065 2,187 2,318 2,418 2,529 2,639
Cash Flow per Share 235.0 239.0 254.0 274.0 292.0 - - -
Capex 1 2,625 3,652 3,414 4,722 6,474 9,580 5,250 4,750
Capex / Sales 2.26% 3.02% 2.89% 3.82% 4.97% 6.97% 3.64% 3.15%
Announcement Date 5/10/19 5/8/20 5/7/21 5/9/22 5/11/23 - - -
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for TOKAI Corp.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
2,100 JPY
Average target price
2,295 JPY
Spread / Average Target
+9.29%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment Wholesale

1st Jan change Capi.
TOKAI CORP. Stock TOKAI Corp.
+0.48% 470M
HENRY SCHEIN, INC. Stock Henry Schein, Inc.
-3.21% 9.4B
OWENS & MINOR, INC. Stock Owens & Minor, Inc.
+32.43% 1.92B
SHIP HEALTHCARE HOLDINGS, INC. Stock Ship Healthcare Holdings, Inc.
-3.90% 1.39B
AS ONE CORPORATION Stock AS ONE Corporation
-7.38% 1.18B
GKHT MEDICAL TECHNOLOGY CO., LTD. Stock GKHT Medical Technology Co., Ltd.
-18.42% 856M
EXCELSIOR MEDICAL CO., LTD. Stock Excelsior Medical Co., Ltd.
+3.62% 437M
GAUSH MEDITECH LTD Stock Gaush Meditech Ltd
-48.57% 360M
COWEALTH MEDICAL CHINA CO.,LTD. Stock Cowealth Medical China Co.,Ltd.
-24.72% 333M
WIN-PARTNERS CO., LTD. Stock WIN-Partners Co., Ltd.
-2.42% 212M
Medical Equipment Wholesale
  1. Stock Market
  2. Equities
  3. 9729 Stock
  4. Financials TOKAI Corp.